Most assisted reproductive technologies (ART) are used to treat infertility. Others are used when there are no fertility problems. Embryo screening or pre-implantation genetic diagnosis, for example, is used in order to prevent the births of children with specific genetic characteristics.
In vitro fertilization (IVF) refers to assisted reproduction procedures in which sperm and eggs are joined outside a woman's body. Women undergoing IVF are given hormonal drugs to promote the development of multiple eggs, which are retrieved with a minor surgical procedure. The eggs are mixed with sperm; one or more of those that fertilize are then transferred to the woman's uterus.
IVF has been in use since 1978 and has resulted in almost four million births worldwide. A number of IVF-related techniques have been introduced since then. Some of these, such as pre-implantation genetic diagnosis and commercial gestational surrogacy, raise significant ethical and policy concerns. In the United States alone, the assisted reproduction business is estimated to create over $3 billion in revenues a year.
Research on the risks associated with ART is notoriously inadequate. There have been few follow-up studies either on women who have used ARTs or their children. The United States is also known for having few laws governing assisted reproduction and little oversight of ART facilities.
The Genome Engineering Revolutionby Ryan Clarke and James Hyun, Tech CrunchMay 13th, 2015The CRISPR-cas9 system makes gene editing in many organisms and cells — like our own egg, sperm or embryo — more efficient, accessible and simple than ever before.
Stopping or Selling Human Germline Modification?by Pete Shanks, Biopolitical TimesMay 7th, 2015Debate about human germline engineering has taken off since publication of a paper describing failed attempts to genetically modify a human embryo.